A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.30
- USD1.73
- USD1.27
- USD4.40
- 17.90%
- --
- 184.74k
- 27.54k
- 27M
- 0.85
- -35.60%
Stock News
yesterday
Jim Cramer says holding Home Depot stock is a good idea
CNBC
yesterday
Micron gets boost with surging AI memory-chip sales; shares jump on earnings beat
MarketWatch
yesterday
The 10 most expensive places in the U.S. to start a new business, report finds
CNBC
yesterday
We're adding a well-known tech stock to our Bullpen watchlist after Nvidia's big AI event
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
